CLINICAL_TRIALS
trial_result
· 2022-06-30
Clinical Trial Update: Eye Tracking as a Biomarker of Cannabis Effects [Phase 2]
Summary
Phase 2 trial investigating eye tracking as a biomarker of cannabis effects; the study was terminated with results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: New York State Psychiatric Institute | Conditions: Cannabis Use, Pain, Acute | Phase 2 | Status: TERMINATED | Results posted: 2022-06-30